Syngene International Appoints Deepak Jain As CFO; Dr. Jayashree Aiyar As CSO

The Board of Directors of Syngene International Limited has approved the appointment of Deepak Jain as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), which will be effective from December 1, 2024. He will replace Sibaji Biswas, whose resignation was approved by the Board, and his last working day would be November 30, 2024.

The Board also approved the appointment of Dr. Jayashree Aiyar as Chief Scientific Officer and a member of the Executive Committee (Senior Management Personnel) w.e.f. October 23, 2024.

Deepak joined Syngene in September 2024 from Ather Energy as the Chief Financial Officer. Prior to that, he was the India CFO for First Advantage and for Apple. He was part of the team that led Apple’s expansion in the Indian market. He has also held leadership roles at Procter & Gamble and Ernst & Young India. He has over 25 years of experience, and he is a Chartered Accountant with a Bachelor of Commerce Degree from Calcutta University.

Jayashree joined Syngene in 2016 as VP and Head of Discovery Biology. She has over 25 years of experience as a molecular pharmacologist and has led drug discovery projects in global organisations like AstraZeneca, Merck, Ambrx, and Theravance in the US and Jubilant Biosys in India. She holds a PhD in immunology from the All India Institute of Medical Sciences, New Delhi. She pursued her postdoctoral research at the California Institute of Technology and the University of California at Irvine.